Wangxue Chen
7Patents
3h-index
13Co-inventors
50Inventor score
Filing activity: Mar 20, 2008 → Sep 18, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9327022B2 | BSA-specific antibodies | Chemistry; Metallurgy | 23 | Active |
| US10092644B2 | Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants | Human Necessities | 10 | Active |
| US10406221B2 | Lipidated Streptococcus pneumoniae antigen compositions, methods of preparation and use | Emerging Cross-Sectional Technologies | 3 | Active |
| US10357560B2 | Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants | Human Necessities | 0 | Active |
| US11744884B2 | Live Salmonella typhi vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US8758763B2 | Archaeal polar lipid aggregates for administration to animals | Human Necessities | 0 | Active |
| US8834895B2 | Use of Francisella tularensis for prevention and treatment of allergic airway disorders | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.